No Data
Roche Finalizes Tender Offer for $1.5B Poseida Biopharma Deal
Roche (RHHBY.US) will complete the acquisition of the American biopharmaceutical company Poseida (PSTX.US) for 1.5 billion USD.
Roche announced on Wednesday that it plans to complete the acquisition of the USA biopharmaceutical company Poseida Therapeutics.
Roche to Complete Takeover of Poseida Therapeutics After Tender Offer Closes
Roche: 66.11% of Poseida's Shares Were Validly Tendered in Offer
Roche Intends to Complete Acquisition of Poseida Therapeutics Later Wednesday
FDA Issues Draft Guidance on Developing Weight Loss Drugs
s get in your head.
Ryand83 OP : @BadPaint do some deep dives on GSAT bud
.
72464536 : thx for the tips!
BadPaint Ryand83 OP : Let’s take a look…
BadPaint BadPaint : Thanks for the GSAT play Ryan! This looks gnarly with a lot of potential with the partnership of Apple funding a constelltion of satellite expansion.
Ryand83 OP BadPaint :
my only concern is even after the uplist reverse split the share count will still be 100m or so. Wonder if it will pump pre-split